Gsk Plc · LSE:GSK

Gsk — Morgan Stanley ESG Insights Conference 2021

12 slides from Gsk's conference presentation, Dec 2, 2021

  1. Slide 1: Harmony P Garges, MD MPH

    Harmony P Garges, MD MPH Chief Medical Officer | ViiV Healthcare / Chief Medical Officer and Head of Global Medical for ViiV Healthcare, the only pharmaceutical company 100% focused on HIV. / Accountable for all aspects of human safety and medical governance for the company and leads the medical aff

  2. Slide 2: ViiV Healthcare: On a global pursuit to leave no person living with HIV behind

    ViiV Healthcare: On a global pursuit to leave no person living with HIV behind Dr Harmony P Garges Chief Medical Officer 2 December 2021

  3. Slide 3: Our commitment to ESG

    Our commitment to ESG Environmental Social Governance 3

  4. Slide 4: Warren, Living with HIV

    Warren Living with HIV Alabama, US 4

  5. Slide 5: Decades of progress have changed the HIV epidemic

    Decades of progress have changed the HIV epidemic 1 1. CDC. MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):689-93. 5

  6. Slide 6: But the HIV epidemic is not over

    Amilcar Living with HIV But the HIV epidemic is not over Portugal 37.9 million people are eligible Continued HIV transmission for antiretroviral therapy 1.5 million new cases each year3 Under the ‘Treat All’ approach advocated by WHO’s guidelines1,2 COVID-19 impacting progress Access to treatment is

  7. Slide 7: HIV treatment and prevention are about more than medicine

    HIV treatment and prevention are about more than medicine Clinical Trial Diversity Improving Task Force health disparities Provides the clear case for why action is needed Identifies stakeholders who can combat disparities Brings forth the actions that can be taken to Reframing Risk address disparit

  8. Slide 8: ViiV Healthcare – focused on ending HIV and AIDS

    ViiV Healthcare – focused on ending HIV and AIDS Our mission is to leave no person Leaders and Focused and Built on novel Strong commitment living with HIV disruptors in agile, backed by collaborations and to communities behind. innovation scale of GSK powerful partnerships 2009 2012 2013 2016 2019

  9. Slide 9: Our commitment to paediatrics

    Our commitment to paediatrics Through our scientific research, innovative partnerships and local 1.7 million Children under 15 years of age community work, we are are living with HIV addressing gaps in paediatric HIV treatment and accelerating access to medicines for infants and children around the

  10. Slide 10: Our commitment to access

    Our commitment to access Making our medicines as widely available to patients regardless of income or where they live Access and care to all and each PLHIV Alignment with the global Taking an innovative, HIV response and agenda responsible and, above all, set by UNAIDS and the sustainable approach S

  11. Slide 11: Our commitment to community

    Eddie Living with HIV Our commitment to community Florida, US 100+ projects selected for ViiV COVID-19 Emergency Response Fund 11

  12. Slide 12: To leave no person living with HIV behind

    To leave no person living with HIV behind Visit ViiVHealthcare.com to learn more Yulia, Living with HIV, St Petersburg, Russia 12

GSK — Morgan Stanley ESG Insights Conference 2021 on 6ix